PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

secukinumab

Verify with FDA → · CMS NADAC pricing →

Brand names: Cosentyx

IL-17A Inhibitor (Biologic) Rx

Cosentyx is a medicine that can help reduce inflammation in your body. It is used to treat several conditions, including psoriasis and arthritis.

Drug Pricing (NADAC)

Brand Price

$7206.70/unit

Generic Available

No

Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →

What it does

Cosentyx treats moderate to severe plaque psoriasis in patients 6 years and older.

Common side effects

Common cold (nasopharyngitis), Diarrhea, Upper respiratory tract infection

Key warnings

Cosentyx may increase your risk of getting serious infections.

How It Works

Cosentyx is a type of medicine called an interleukin-17A (IL-17A) inhibitor. IL-17A is a protein in the body that causes inflammation. Cosentyx blocks IL-17A, which helps to reduce inflammation and the symptoms of certain diseases.

How to Take It

Cosentyx can be given as a shot under the skin (subcutaneous injection) or through a needle into your vein (intravenous infusion). Before starting Cosentyx, you need to get all your vaccines and be tested for tuberculosis (TB). Your doctor will tell you how much Cosentyx to take and how often. Follow your doctor's instructions carefully.

Pregnancy & Breastfeeding

Tell your doctor if you are pregnant or plan to become pregnant. It is not known if Cosentyx will harm your unborn baby. Talk to your doctor about the risks and benefits of using Cosentyx if you are breastfeeding.

Missed Dose

If you miss a dose of Cosentyx, take it as soon as you remember. Then, continue with your regular schedule.

Storage

Keep Cosentyx in the refrigerator between 36°F and 46°F (2°C and 8°C) in its original container to protect from light. Do not freeze or shake.

Side Effects (from patient reports)

Based on 137,088 FDA adverse event reports.

The medicine is not working
28,717
Psoriasis
22,567
Pain
16,136
Joint pain
14,488
Tiredness
10,192
Psoriatic arthritis
9,805
Itching
9,168
Feeling unwell
9,100
Skin rash
8,709
Condition getting worse
8,206

FDA Adverse Event Report Analysis

Detailed analysis of 157,236 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2012–2025.

Total Reports

157,236

Death-Related Reports

7,752

Hospitalization Reports

20,636

Top Indication

Psoriasis

Gender Distribution

Female 90,501 (62%)
Male 55,361 (38%)

Age Distribution

0–17 480
18–44 19,834
45–64 30,760
65–74 8,814
75+ 3,233

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
1 DRUG INEFFECTIVE 28,717
2 PSORIASIS 22,567
3 PAIN 16,136
4 ARTHRALGIA 14,488
5 FATIGUE 10,192
6 PSORIATIC ARTHROPATHY 9,805
7 PRURITUS 9,168
8 MALAISE 9,100
9 RASH 8,709
10 CONDITION AGGRAVATED 8,206
11 DIARRHOEA 7,681
12 NASOPHARYNGITIS 7,487
13 PAIN IN EXTREMITY 7,099
14 HEADACHE 6,938
15 OFF LABEL USE 6,356

Reactions in Death Reports

DEATH 2,376
OFF LABEL USE 2,187
SYSTEMIC LUPUS ERYTHEMATOSUS 2,110
PSORIATIC ARTHROPATHY 2,092
TYPE 2 DIABETES MELLITUS 2,053
SYNOVITIS 2,047
GENERAL PHYSICAL HEALTH DETERIORATION 2,039
HYPOAESTHESIA 2,035
GLOSSODYNIA 2,032
RASH 2,026

Reactions in Hospitalization Reports

PAIN 4,036
FATIGUE 3,589
ARTHRALGIA 3,559
MALAISE 3,362
DRUG INEFFECTIVE 3,258
PSORIATIC ARTHROPATHY 3,086
OFF LABEL USE 3,063
DIARRHOEA 2,916
RASH 2,913
JOINT SWELLING 2,850

Source: FDA FAERS (Adverse Event Reporting System) FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

Cosentyx may increase your risk of getting serious infections. Tell your doctor if you have any infections or a history of infections. If you have a serious allergic reaction, stop using Cosentyx right away and get medical help.

Common Questions

What should I do if I have an allergic reaction to Cosentyx?
Stop using Cosentyx immediately and get medical help right away.
Can Cosentyx be used in children?
Yes, Cosentyx can be used to treat plaque psoriasis in children 6 years and older, psoriatic arthritis in children 2 years and older, and enthesitis-related arthritis in children 4 years and older.
Does Cosentyx interact with other medications?
Cosentyx may affect how some other medicines work. Tell your doctor about all the medicines you take.
How is Cosentyx given?
Cosentyx is given as a shot under the skin (subcutaneous injection) or through a needle into your vein (intravenous infusion).
What if I have a chronic infection?
Tell your doctor if you have a chronic infection or a history of recurrent infection before starting Cosentyx.
Can I get live vaccines while taking Cosentyx?
Avoid live vaccines while taking Cosentyx.
What are the common side effects of Cosentyx?
The most common side effects are common cold, diarrhea, and upper respiratory tract infection.
What should I do if I develop an infection while taking Cosentyx?
Tell your doctor right away if you develop any signs or symptoms of an infection.
How should I store Cosentyx?
Store Cosentyx in the refrigerator and protect it from light. Do not freeze.
What if I have inflammatory bowel disease (IBD)?
Tell your doctor if you have IBD, as Cosentyx may affect this condition.
What are the common side effects of secukinumab?
The most commonly reported side effects of secukinumab include Common cold (nasopharyngitis), Diarrhea, Upper respiratory tract infection. Based on 137,088 FDA adverse event reports. Always consult your healthcare provider about potential side effects.
What drug class is secukinumab?
secukinumab belongs to the IL-17A Inhibitor (Biologic) drug class. It requires a prescription (Rx). Cosentyx treats moderate to severe plaque psoriasis in patients 6 years and older.
Is secukinumab safe during pregnancy?
Tell your doctor if you are pregnant or plan to become pregnant. It is not known if Cosentyx will harm your unborn baby. Always consult your healthcare provider before using any medication during pregnancy or breastfeeding.

Related Medications in IL-17A Inhibitor (Biologic)

Other drugs grouped near secukinumab — same-class peers and common alternatives.

Compare secukinumab vs abatacept side-by-side →

Medication Guides

Related Health & Safety Data

Save on secukinumab

Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.

Disclosure: This link may earn us a commission at no extra cost to you. See our terms.

What the FDA Data Shows for secukinumab

The FDA label for secukinumab (sold under brand names such as Cosentyx) classifies it as a prescription-only medication in the IL-17A Inhibitor (Biologic) class. Cosentyx treats moderate to severe plaque psoriasis in patients 6 years and older. Official labeling lists 3 commonly reported side effects, including Common cold (nasopharyngitis), Diarrhea, Upper respiratory tract infection.

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 137,088 voluntary reports. Interaction data is drawn directly from FDA-approved prescribing information. NADAC pricing from CMS.

Report counts do not establish causation — a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice — always consult a licensed healthcare provider before starting, stopping, or changing any medication.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.

Last updated: December 12, 2025

All federal data sources used on this page